US EditionInsulin receptor degradation in Nonalcoholic Fatty Liver Disease and obesity - BioPatrika
Summary by biopatrika.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
Insulin receptor degradation in Nonalcoholic Fatty Liver Disease and obesity - BioPatrika
Investigating the mechanism of insulin receptor degradation by the new E3 ubiquitin ligase TRIM32 in the context of Nonalcoholic Fatty Liver Disease and obesity. Author interview: Shilpa Thakur joined the Ph.D. programme in 2020 in the School of Biosciences and Bioengineering at IIT Mandi. She is investigating the mechanisms of insulin action to identify sites and […] The post Insulin receptor degradation in Nonalcoholic Fatty Liver Disease and …
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
